A Review on Indole as a Cardinal Scaffold for Anticancer Drugs Development
- 1 July 2024
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 20 (4) , 372-385
Abstract
Chemotherapy is the mainstay of therapeutic cancer therapy; however, development of resistance typically makes it less effective. There are continuous efforts by the researchers to find novel lead compounds with potent anti-cancer activity. Generally, synthetic or natural heterocyclic compounds have been investigated in detail as a scaffold for cancer therapeutics. Among them, indole owing to its unique physiochemical and biological properties provides a promising platform for the development of pharmacaphore for drugs development against cancer, acting via various mechanisms. Till now, several indole based derivatives have been identified as anti-cancer agents which are either being used in clinics or are in various phases of clinical trials, suggesting their importance in anti-cancer drug development. These anti-cancer drugs have been classified into different classes depending upon their mechanism of action. For example, histone deacetylase inhibitors (HDAC inhibitors), silent mating type information regulation 2 homolog (SIRT) inhibitors, tubulin inhibitors, proviral insertion site in moloney murine leukemia virus (Pim) inhibitors, DNA Topoisomerase inhibitors, and kinase inhibitors. In this review, the authors approach is to compile the recent development on indole-based anti-cancer drugs and provide an insight into the respective structure activity relationships (SARs) of the compounds. We hope the review will provide a thorough understanding to the reader and guide to develop novel and potent indole based anticancer agents against drug-sensitive and drug-resistant cancer in future.Keywords
This publication has 101 references indexed in Scilit:
- Indole derivatives targeting colchicine binding site as potential anticancer agentsArchiv der Pharmazie, 2023
- Light‐Triggered Efficient Sequential Drug Delivery of Biomimetic Nanosystem for Multimodal Chemo‐, Antiangiogenic, and Anti‐MDSC Therapy in MelanomaAdvanced Materials, 2022
- Evaluation of a Tubulin‐Targeted Pyrimidine Indole Hybrid Molecule as an Anticancer AgentChemistrySelect, 2020
- Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding siteBioorganic Chemistry, 2019
- Tetrahydroindoles as Multipurpose Screening Compounds and Novel Sirtuin InhibitorsChemMedChem, 2019
- Novel anti-cancer agents: design, synthesis, biological activity, molecular docking, and MD simulations of 2, 3, 4, 5-tetrahydro-1H-pyrido-[4,3-b]indole derivativesMedicinal Chemistry Research, 2018
- Tumor targeting via EPR: Strategies to enhance patient responsesAdvanced Drug Delivery Reviews, 2018
- Synthesis and Biological Evaluation of 1‐Methyl‐1H‐indole–Pyrazoline Hybrids as Potential Tubulin Polymerization InhibitorsChemMedChem, 2016
- Fascaplysin Induces Caspase Mediated Crosstalk Between Apoptosis and Autophagy Through the Inhibition of PI3K/AKT/mTOR Signaling Cascade in Human Leukemia HL‐60 CellsJournal of Cellular Biochemistry, 2015
- Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinomaTumor Biology, 2014